These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6107939)

  • 21. Beta-blockers as antiarrhythmic agents.
    Zicha S; Tsuji Y; Shiroshita-Takeshita A; Nattel S
    Handb Exp Pharmacol; 2006; (171):235-66. PubMed ID: 16610347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia.
    Podrid PJ; Fuchs T; Candinas R
    Circulation; 1990 Aug; 82(2 Suppl):I103-13. PubMed ID: 1973640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology.
    Mason DT; DeMaria AN; Amsterdam EA; Zelis R; Massumi RA
    Drugs; 1973; 5(4):261-91. PubMed ID: 4146767
    [No Abstract]   [Full Text] [Related]  

  • 24. [Variability of heart rate in postmyocardial infarction patients: clinical implications, problems and prospects].
    Popov VV; Kopitsa NP; Oparin AL
    Klin Med (Mosk); 1998; 76(2):15-9. PubMed ID: 9553353
    [No Abstract]   [Full Text] [Related]  

  • 25. [Adrenergic receptors and cardiac membrane potential].
    Hirakawa S; Inagaki T
    Saishin Igaku; 1970 Apr; 25(4):873-8. PubMed ID: 4393008
    [No Abstract]   [Full Text] [Related]  

  • 26. [Interrelationship between electrophysiological markers of arrhythmogenicity and psychoemotional status of patients with myocardial infarction].
    Lebedeva NB; Lebedev OV; Berns SA; Barbarash LS; Barbarash NA; Barbarash OL
    Kardiologiia; 2003; 43(2):70-1. PubMed ID: 12913989
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical trials of antiarrhythmic drugs in postmyocardial infarction and congestive heart failure patients.
    Camm AJ; Yap YG
    J Cardiovasc Pharmacol Ther; 2001 Jan; 6(1):99-106. PubMed ID: 11452341
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical pharmacology of antiarrhythmic agents.
    Kelliher GJ; Kowey P; Engel T; Wetstein L
    Cardiovasc Clin; 1985; 16(1):287-305. PubMed ID: 2874883
    [No Abstract]   [Full Text] [Related]  

  • 29. New drugs for the treatment of cardiac arrhythmias.
    Bump TE; Arnsdorf MF
    Compr Ther; 1980 Jun; 6(6):63-72. PubMed ID: 6103779
    [No Abstract]   [Full Text] [Related]  

  • 30. [The role of beta-blocking agents in the treatment of cardiac dysrhythmia (author's transl)].
    Clémenty J; Dallocchio M; Lévy S; Bricaud H
    Ann Cardiol Angeiol (Paris); 1976 Dec; 25(6):535-42. PubMed ID: 13701
    [No Abstract]   [Full Text] [Related]  

  • 31. Antihypertensive compounds as antiarrhythmic agents: focus on beta-blocking drugs in ventricular arrhythmias.
    Singh BN; Nademanee K
    Am Heart J; 1987 Oct; 114(4 Pt 2):1040-50. PubMed ID: 2444089
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiarrhythmic action of beta-blockers: potential mechanisms.
    Dorian P
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S15-22. PubMed ID: 15965568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical pharmacology of beta adrenergic blocking agents].
    Toyama S; Suzuki K
    Nihon Rinsho; 1973 Sep; 31(9):2687-95. PubMed ID: 4148964
    [No Abstract]   [Full Text] [Related]  

  • 34. [Spectrum of effects of beta receptor blockade in cardiac arrhythmias].
    Lüderitz B
    Z Kardiol; 1986; 75 Suppl 5():41-6. PubMed ID: 2435070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiologic activity and antiarrhythmic efficacy of CK-3579, a new class III antiarrhythmic agent with beta-adrenergic blocking properties.
    Argentieri TM; Troy HH; Carroll MS; Doroshuk CM; Sullivan ME
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):647-55. PubMed ID: 7681912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of action and the clinical pharmacology of beta-adrenergic blocking drugs.
    Lowenthal DT; Saris SD; Packer J; Haratz A; Conry K
    Am J Med; 1984 Oct; 77(4A):119-27. PubMed ID: 6148890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic effects of beta-adrenergic blocking agents in benign or potentially lethal ventricular arrhythmias.
    Morganroth J
    Am J Cardiol; 1987 Aug; 60(6):10D-14D. PubMed ID: 2888297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 39. Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
    Singh BN; Jewitt DE
    Drugs; 1974; 7(6):426-61. PubMed ID: 4153572
    [No Abstract]   [Full Text] [Related]  

  • 40. The assessment of antidysrhythmic drugs.
    Levitt B
    J Clin Pharmacol; 1984 Jul; 24(7):328-32. PubMed ID: 6384278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.